Nanoform

Nanoform is a Finland nanotechnology company that specializes in enhancing the bioavailability and solubility of pharmaceutical compounds through its proprietary technology platform. The company was founded in 2015 and is headquartered in Helsinki, Finland.

The company collaborates with pharmaceutical companies to apply its canonization technology to their drug candidates, aiming to improve their therapeutic profiles and clinical outcomes. Nanoform's approach can be particularly beneficial for poorly soluble drugs that have limited absorption or efficacy due to their low bioavailability.

Nanoform specializes in enhancing drug candidate performance through the use of nanoparticles. There are a lot of novel compounds with potential for medicine that are difficult to dissolve, making it difficult for the medications to reach the patient's bloodstream and have the desired effect. The Nanoform particles are made to make these molecules more soluble so they can enter clinical trials and make the formulation process easier. According to the business, this technique may potentially treble the pharmaceutical industry's yearly output of new pharmaceuticals.

Headquarters: Helsinki

Founded: 2015

Webiste: https://nanoform.com